DE69611796D1 - Verfahren zur herstellung von galanthamin und deren derivaten - Google Patents
Verfahren zur herstellung von galanthamin und deren derivatenInfo
- Publication number
- DE69611796D1 DE69611796D1 DE69611796T DE69611796T DE69611796D1 DE 69611796 D1 DE69611796 D1 DE 69611796D1 DE 69611796 T DE69611796 T DE 69611796T DE 69611796 T DE69611796 T DE 69611796T DE 69611796 D1 DE69611796 D1 DE 69611796D1
- Authority
- DE
- Germany
- Prior art keywords
- derivatives
- crushed
- compound
- bulbs
- galanthamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9519268.8A GB9519268D0 (en) | 1995-09-21 | 1995-09-21 | Preparation of alkaloids |
PCT/GB1996/002335 WO1997011078A1 (en) | 1995-09-21 | 1996-09-23 | Process for the preparation of galanthamine and its derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69611796D1 true DE69611796D1 (de) | 2001-03-22 |
DE69611796T2 DE69611796T2 (de) | 2001-10-11 |
Family
ID=10781039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69611796T Expired - Lifetime DE69611796T2 (de) | 1995-09-21 | 1996-09-23 | Verfahren zur herstellung von galanthamin und deren derivaten |
Country Status (12)
Country | Link |
---|---|
US (1) | US6184004B1 (de) |
EP (1) | EP0853624B1 (de) |
AT (1) | ATE199153T1 (de) |
AU (1) | AU710980B2 (de) |
CA (1) | CA2230824C (de) |
DE (1) | DE69611796T2 (de) |
DK (1) | DK0853624T3 (de) |
ES (1) | ES2155200T3 (de) |
GB (1) | GB9519268D0 (de) |
GR (1) | GR3035752T3 (de) |
PT (1) | PT853624E (de) |
WO (1) | WO1997011078A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT403803B (de) | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
EP1181294B1 (de) | 2000-03-31 | 2004-03-31 | Sanochemia Pharmazeutika Aktiengesellschaft | Neue derivate und analoga von galanthamin |
JP4029960B2 (ja) * | 2001-10-05 | 2008-01-09 | 独立行政法人理化学研究所 | アブシジン酸生合成阻害剤 |
WO2005065662A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Solid dosage formulations of galantamine |
WO2005065661A2 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Immediate, controlled and sustained release formulations of galanthamine |
EP2316437B1 (de) * | 2005-05-13 | 2014-07-30 | Alza Corporation | Mehrschichtiges Arzneimittelabgabesystem mit Barriere gegen Reservoirmaterialfluss |
WO2007035941A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | Transdermal galantamine delivery system |
AT504663B1 (de) * | 2007-02-22 | 2008-07-15 | Sanochemia Pharmazeutika Ag | Verfahren zum herstellen von hochreinen 4a,5,9,10,11,12,-hexahydro-6h-benzofuro(3a,3,2- f)(2) benzazepinen sowie dessen derivaten |
CN104592243B (zh) * | 2014-12-19 | 2016-08-24 | 北京大学 | 加兰他敏和力克拉敏的不对称合成方法 |
BG67337B1 (bg) | 2018-05-23 | 2021-06-15 | Софарма Ад | Метод за получаване на пречистен галантамин хидробромид |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4290862A (en) * | 1979-11-14 | 1981-09-22 | Edinen Centar P Chimia | Method for the preparation of narwedine-type enones |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
US5428159A (en) * | 1994-04-08 | 1995-06-27 | Ciba-Geigy Corporation | Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine |
-
1995
- 1995-09-21 GB GBGB9519268.8A patent/GB9519268D0/en active Pending
-
1996
- 1996-09-23 DK DK96931170T patent/DK0853624T3/da active
- 1996-09-23 US US09/043,598 patent/US6184004B1/en not_active Expired - Lifetime
- 1996-09-23 WO PCT/GB1996/002335 patent/WO1997011078A1/en active IP Right Grant
- 1996-09-23 AT AT96931170T patent/ATE199153T1/de active
- 1996-09-23 CA CA002230824A patent/CA2230824C/en not_active Expired - Lifetime
- 1996-09-23 PT PT96931170T patent/PT853624E/pt unknown
- 1996-09-23 AU AU69965/96A patent/AU710980B2/en not_active Expired
- 1996-09-23 EP EP96931170A patent/EP0853624B1/de not_active Expired - Lifetime
- 1996-09-23 ES ES96931170T patent/ES2155200T3/es not_active Expired - Lifetime
- 1996-09-23 DE DE69611796T patent/DE69611796T2/de not_active Expired - Lifetime
-
2001
- 2001-04-12 GR GR20010400603T patent/GR3035752T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0853624T3 (da) | 2001-05-07 |
PT853624E (pt) | 2001-06-29 |
DE69611796T2 (de) | 2001-10-11 |
WO1997011078A1 (en) | 1997-03-27 |
US6184004B1 (en) | 2001-02-06 |
ES2155200T3 (es) | 2001-05-01 |
GR3035752T3 (en) | 2001-07-31 |
AU6996596A (en) | 1997-04-09 |
ATE199153T1 (de) | 2001-02-15 |
CA2230824A1 (en) | 1997-03-27 |
CA2230824C (en) | 2009-09-15 |
GB9519268D0 (en) | 1995-11-22 |
EP0853624B1 (de) | 2001-02-14 |
AU710980B2 (en) | 1999-10-07 |
EP0853624A1 (de) | 1998-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69611796T2 (de) | Verfahren zur herstellung von galanthamin und deren derivaten | |
DE69719781D1 (de) | Zwischenprodukte zur Herstellung von Duocarmycin SA und dessen Derivaten sowie ein Verfahren zur Herstellung der Zwischenprodukte | |
DE69325031T2 (de) | Verfahren zur herstellung von taxanderivaten | |
ATE89128T1 (de) | Stabilisierter futtermittelzusatz und verfahren zu seiner herstellung. | |
DE69419662D1 (de) | Verfahren zur Herstellung von Benzyliden-Derivaten | |
ATE95836T1 (de) | Zum abbau von glycosaminoglycan faehige enzymzusammensetzung und verfahren zur herstellung dieser zusammensetzung. | |
ATE197706T1 (de) | Anellierte dihydropyridine und deren verwendung für die herstellung von pharmazeutischen zubereitungen | |
DE69728180D1 (de) | Verfahren zur herstellung von carbamoylsubstituierten imidazolderivaten | |
ATE197150T1 (de) | Verfahren zur herstellung von dihydroxypyrimidin- derivaten | |
DE69627472T2 (de) | Verfahren zur Herstellung von Platin Verbindungen | |
DE69619685D1 (de) | Galanthaminderivate und verfahren zu deren herstellung | |
DE58907409D1 (de) | Verfahren zur Herstellung von Caprolactam. | |
DE3774954D1 (de) | Verfahren zur herstellung von penemen. | |
ATE231867T1 (de) | Stereoselektives verfahren zur herstellung von dihydro-2,3-benzodiazepin-derivaten | |
DE59709792D1 (de) | Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung | |
DE3685337D1 (de) | Verfahren zur herstellung von amiden unter verwendung von mikroorganismen. | |
DE3863136D1 (de) | Derivate des 2,2-bis-(3-aminophenyl)-hexafluorpropans und verfahren zur herstellung des 2,2-bis-(3,4-diaminophenyl)-hexafluorpropans. | |
DE69729631D1 (de) | Verfahren zur herstellung von granisetron | |
DE69518252T2 (de) | Verfahren zur herstellung von 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalin-derivaten | |
ATE242218T1 (de) | Verfahren zur herstellung von imidazolinderivaten | |
DE59508739D1 (de) | Verfahren zur herstellung von 2-piperazincarbonsäurederivaten | |
AT387214B (de) | Verfahren zur herstellung neuer n-substituierter, estergruppen enthaltender acrylamide | |
ATE217316T1 (de) | Verfahren zur herstellung von diphosphonat- derivaten | |
DE59907569D1 (de) | Verfahren zur herstellung von optisch aktiven 1- amino-4- (hydroxymethyl)- cyclopent-2- en-derivaten | |
ATE76065T1 (de) | Herstellung von azetidinonen und zwischenprodukten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: JANSSEN PHARMACEUTICA N.V., BEERSE, BE |
|
8332 | No legal effect for de | ||
8370 | Indication related to discontinuation of the patent is to be deleted | ||
8364 | No opposition during term of opposition |